BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9558070)

  • 1. Modulation of naive CD4 T cell activation with altered peptide ligands: the nature of the peptide and presentation in the context of costimulation are critical for a sustained response.
    Rogers PR; Grey HM; Croft M
    J Immunol; 1998 Apr; 160(8):3698-704. PubMed ID: 9558070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of IL-4-producing CD4+ T cells by antigenic peptides altered for TCR binding.
    Tao X; Grant C; Constant S; Bottomly K
    J Immunol; 1997 May; 158(9):4237-44. PubMed ID: 9126985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
    Ding L; Shevach EM
    J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.
    Gramaglia I; Weinberg AD; Lemon M; Croft M
    J Immunol; 1998 Dec; 161(12):6510-7. PubMed ID: 9862675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The minimal number of antigen-major histocompatibility complex class II complexes required for activation of naive and primed T cells.
    Kimachi K; Croft M; Grey HM
    Eur J Immunol; 1997 Dec; 27(12):3310-7. PubMed ID: 9464819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of phospholipase C-gamma 1 and mitogen-activated protein kinase in naive and antigen-primed CD4 T cells by the peptide/MHC ligand.
    Ericsson PO; Orchansky PL; Carlow DA; Teh HS
    J Immunol; 1996 Mar; 156(6):2045-53. PubMed ID: 8690891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells.
    Croft M; Joseph SB; Miner KT
    J Immunol; 1997 Oct; 159(7):3257-65. PubMed ID: 9317124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance.
    Rogers PR; Croft M
    J Immunol; 1999 Aug; 163(3):1205-13. PubMed ID: 10415015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 regulation of TCR signaling and T cell differentiation following stimulation with peptides of different affinities for the TCR.
    Leitenberg D; Boutin Y; Constant S; Bottomly K
    J Immunol; 1998 Aug; 161(3):1194-203. PubMed ID: 9686579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity.
    Krogsgaard M; Li QJ; Sumen C; Huppa JB; Huse M; Davis MM
    Nature; 2005 Mar; 434(7030):238-43. PubMed ID: 15724150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
    Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand.
    Abraham C; Griffith J; Miller J
    J Immunol; 1999 Apr; 162(8):4399-405. PubMed ID: 10201975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: dueling TCRs: peptide antagonism of CD4+ T cells with dual antigen specificities.
    Robertson JM; Evavold BD
    J Immunol; 1999 Aug; 163(4):1750-4. PubMed ID: 10438905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells.
    Croft M; Bradley LM; Swain SL
    J Immunol; 1994 Mar; 152(6):2675-85. PubMed ID: 7908301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct observation of ligand recognition by T cells.
    Irvine DJ; Purbhoo MA; Krogsgaard M; Davis MM
    Nature; 2002 Oct; 419(6909):845-9. PubMed ID: 12397360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro production of antigen-specific T cells from unprimed mice: role of dexamethasone and anti-IL-10 antibodies.
    Dozmorov I; Miller RA
    Cell Immunol; 1997 Jun; 178(2):187-96. PubMed ID: 9225010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutual regulation between B7-1 (CD80) expressed on T cells and IL-4.
    Schweitzer AN; Sharpe AH
    J Immunol; 1999 Nov; 163(9):4819-25. PubMed ID: 10528182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Instruction of naive CD4+ T-cell fate to T-bet expression and T helper 1 development: roles of T-cell receptor-mediated signals.
    Ariga H; Shimohakamada Y; Nakada M; Tokunaga T; Kikuchi T; Kariyone A; Tamura T; Takatsu K
    Immunology; 2007 Oct; 122(2):210-21. PubMed ID: 17490433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity. I. Use of peptide libraries to identify epitopes that activate clonotypic CD4+ T cells and induce T cell responses to native peptide ligands.
    Wilson DB; Pinilla C; Wilson DH; Schroder K; Boggiano C; Judkowski V; Kaye J; Hemmer B; Martin R; Houghten RA
    J Immunol; 1999 Dec; 163(12):6424-34. PubMed ID: 10586032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.